Qin Ning, Duan Yinglong, Shi Shuangjiao, Li Xiao, Liu Haoqi, Zheng Feng, Zhong Zhuqing, Xiang Guliang
Nursing Department, The Third Xiangya Hospital of Central South University, Changsha, China.
Department of Emergency, The Third Xiangya Hospital of Central South University, Changsha, China.
Ther Adv Drug Saf. 2023 Mar 27;14:20420986231152934. doi: 10.1177/20420986231152934. eCollection 2023.
Patient medication safety can affect their clinical outcomes and plays an important role in patient safety management. However, few tools have been developed to assess patient medication safety. This study aimed to develop and validate the self-reported patient medication safety scale (SR-PMSS).
We developed SR-PMSS guided by the Donabedian Structure-Process-Outcome framework and used psychometric methods to test its validity and reliability.
A total of 501 patients with an average age of 56.81 ± 14.47 were enrolled in this study. The SR-PMSS consisted of 21 items and 5 factors. The content validity was good with item-level content validity index (CVI) > 0.78, average scale-level CVI (S-CVI) > 0.9, and universal agreement S-CVI > 0.8. Exploratory factor analysis extracted a five-factor solution with eigenvalues > 0.1, explaining 67.766% of the variance. Confirmatory factor analysis showed good model fit, acceptable convergent validity, and discriminant validity. The Cronbach's α coefficient for SR-PMSS was 0.929, the split-half reliability coefficient was 0.855, and the test-retest reliability coefficient was 0.978.
The SR-PMSS was a valid and reliable instrument with good reliability and validity to evaluate the level of patient medication safety. The target users of the SR-PMSS are all people who are taking or have used prescription medications. The SR-PMSS can be used by healthcare providers in clinical practice and research to identify patients at risk for medication use and intervene with them to reduce adverse medication events and provide support for patient safety management.
患者用药安全会影响其临床结局,在患者安全管理中发挥着重要作用。然而,用于评估患者用药安全的工具却很少。本研究旨在开发并验证患者自我报告用药安全量表(SR-PMSS)。
我们在唐纳贝迪安结构-过程-结果框架的指导下开发了SR-PMSS,并使用心理测量方法测试其有效性和可靠性。
本研究共纳入501例患者,平均年龄为56.81±14.47岁。SR-PMSS由21个条目和5个因子组成。内容效度良好,条目水平的内容效度指数(CVI)>0.78,量表平均水平的CVI(S-CVI)>0.9,全体一致的S-CVI>0.8。探索性因子分析提取出一个特征值>0.1的五因子解,解释了67.766%的方差。验证性因子分析显示模型拟合良好,具有可接受的收敛效度和区分效度。SR-PMSS的Cronbach's α系数为0.929,分半信度系数为0.855,重测信度系数为0.978。
SR-PMSS是一种有效且可靠的工具,具有良好的信效度,可用于评估患者用药安全水平。SR-PMSS的目标用户是所有正在服用或曾经使用过处方药的人。医疗服务提供者可在临床实践和研究中使用SR-PMSS来识别用药风险患者,并对他们进行干预,以减少用药不良事件,为患者安全管理提供支持。